Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
04/2003
04/17/2003WO1999065318A3 Geminally substituted amines
04/17/2003US20030073845 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
04/17/2003US20030073745 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
04/17/2003US20030073712 Antiinflamamtory agents; antiischemic agents
04/17/2003US20030073701 Succinoylamino heterocycles as inhibitors of a beta protein production
04/17/2003US20030073685 Nitric oxide synthase inhibitor; antiinflammatory agents
04/17/2003US20030073680 Therapy for Tay-sach, Gaucher diseases
04/17/2003US20030073671 Side effect reduction; hormone replacement therapy
04/17/2003US20030073641 Novel N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
04/17/2003US20030070241 Substituted 2-aminoalkyl-1,4-Diaminobenzene compounds and oxidation dye precursor compositions containing same
04/17/2003CA2462301A1 Para-amino benzoic acids as integrin antagonists
04/17/2003CA2458453A1 Acylsulfonamides as inhibitors of steroid sulfatase
04/16/2003EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds
04/16/2003EP1301506A1 Cyclic amino acid derivatives
04/16/2003EP1301498A1 Colchinol derivatives as angiogenesis inhibitors
04/16/2003EP1301497A1 Colchinol derivatives as vascular damaging agents
04/16/2003EP1301496A2 Novel coupling components for oxidation colouring agents
04/16/2003EP1301484A2 Capsaicin receptor ligands
04/16/2003EP1301480A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
04/16/2003EP1301472A2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
04/16/2003EP1301467A2 9-substituted minocycline compounds
04/16/2003EP1301466A2 7-substituted tetracycline compounds
04/16/2003EP1301464A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
04/16/2003EP1094812A4 Angiogenesis inhibitors
04/16/2003EP1040095B1 Cyclohexene carboxylates as neuraminidase inhibitors
04/16/2003EP0998451B1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use
04/16/2003EP0966449B1 1,4-diazacycloheptane derivatives and their use in hair oxidation dyes
04/16/2003EP0953563B1 Process for producing depsipeptide derivatives and novel intermediates therefor
04/16/2003EP0649414B1 Opioid diarylmethylpiperazines and piperidines
04/16/2003CN1411435A Novel use of phenyl hetero alkylamine derivatives
04/16/2003CN1411374A Substituted piperazine and piperidine calcium channel blockers
04/16/2003CN1105711C 嘧啶衍生物 Pyrimidine derivatives
04/16/2003CN1105703C Alpha-substituted phenylacetic acid derivative, process for producing same, and agricultural bactericide containing same
04/15/2003US6548684 Coupling of nucleophiles, vinyl compounds or CO with water, alcohols or amines to organic compounds
04/15/2003US6548675 1-Cyclopropylcarbonyl-2-hydroxy(optional),4-isopropylbenzene used as starting materials for 1-((2-hydroxy(optional),4-alkylphenyl)carbonylalkyl-),4-(diphenylmethyl -)piperidine derivatives; antihistamines; antiallergens; bronchodilators
04/15/2003US6548668 Stabilizer for proteins
04/15/2003US6548547 Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators
04/15/2003US6548504 Compounds
04/15/2003US6548502 Preventing disorder selected from pathological gambling, attention deficit disorder with hyperactivity disorder, substance addiction such as drug and alcohol and sex in a mammals by administering pyrido(1,2-a) pyrazine derivatives
04/15/2003US6548498 Substituted indan derivatives
04/15/2003US6548481 A salt form of a dipeptide compound formed from an amino acid and a thiazolidine or pyrrolidine group, and the salts are selected from acetates, tartrates, fumarates, succinates, phosphates and sulfates
04/15/2003CA2097715C Indan derivatives
04/15/2003CA2047375C Piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis
04/10/2003WO2003029233A1 New sulfonamide derivatives as d3-receptor agonists
04/10/2003WO2003029232A1 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
04/10/2003WO2003029200A2 Compounds useful as reversible inhibitors of cysteine proteases
04/10/2003WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof
04/10/2003WO2003029189A1 Process for producing (2-nitrophenyl)acetonitrile derivative and intermediate therefor
04/10/2003WO2003029187A1 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them
04/10/2003WO2003028728A1 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands
04/10/2003WO2002089738A3 Proteomimetic compounds and methods
04/10/2003WO2002018321A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
04/10/2003WO2001066247A8 A nickel-rhenium catalyst for use in reductive amination processes
04/10/2003US20030069422 Process for preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof
04/10/2003US20030069261 Therapy for eating disorders, sexual disorders, psychological disorders
04/10/2003US20030069254 New arylsulfonyl derivatives with 5-HT6 receptor affinity
04/10/2003US20030069250 Anticoagulants
04/10/2003US20030069233 Central nervous system disorders; psychological disorders; Alzheimer's disease
04/10/2003US20030069222 Used as anti-viral agents against the HIV-1 and HIV-2 viruses.
04/10/2003CA2463232A1 Process for producing (2-nitro-phenyl)acetonirtile derivative and intermediate used for synthesis thereof
04/10/2003CA2462110E Phenyl-piperazine derivatives as serotonin reuptake inhibitors
04/10/2003CA2459825A1 Compounds useful as reversible inhibitors of cysteine proteases
04/09/2003EP1300408A1 Antibacterial substituted 7-acylamino-3-(methylhydrazono)methyl-cephalosporins and intermediates
04/09/2003EP1300402A1 Alkoxybenzylamines with antimicrobial properties
04/09/2003EP1299362A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
04/09/2003EP1299356A1 Novel compounds
04/09/2003EP1299352A2 Compounds to treat alzheimer's disease
04/09/2003EP1299351A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives
04/09/2003EP1299350A1 Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness
04/09/2003EP1299349A2 Compounds to treat alzheimer's disease
04/09/2003EP1299346A2 Process for forming an amide bond
04/09/2003EP1299342A1 Method for producing 3,3-diarylpropylamines
04/09/2003EP1198453B1 N-(indolcarbonyl-)piperazin derivatives
04/09/2003EP1001766B1 Compounds for the treatment of ccr5-mediated diseases
04/09/2003EP0674623B1 Bicyclic fibrinogen antagonists
04/09/2003CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds
04/08/2003US6545160 αaminocetic acid derivatives- α4β7 receptor antagonists
04/08/2003US6545153 Anticholesterol agents; antilipemic agents
04/08/2003US6545108 Catalysts containing N-pyrrolyl substituted nitrogen donors
04/08/2003US6545054 Alkenyl and alkynyl compounds as inhibitors of factor Xa
04/08/2003US6545037 Thromboxane A2 (TXA2) receptor and 5HT2 serotonergic receptor antagonists; 3-(6-(((4-chlorophenyl)sulphonyl)amino)-3-((2-(4-methyl-1 -piperazinyl)phenoxy)methyl)-5,6, 7,8-tetrahydro-1-naphthyl)propanoic acid for example
04/08/2003US6545023 For treating rheumatoid arthritis; for examle, 1-(4-(4-fluorophenyl)piperidin-1-yl),3-(2-methoxy-4 -chlorobenzylaminocarbonyl),3-isopropyl-cyclopentane
04/08/2003US6545018 Oxamic acids and derivatives as thyroid receptor ligands
04/08/2003US6544996 1-phenyl-4-(1-[2-aryl]cyclopropyl) methylpiperazines: dopamine receptor ligands
04/08/2003US6544298 Dyeing human hair using coupler
04/08/2003CA2123548C Piperazine derivatives
04/08/2003CA2109830C Lhrh antagonists and intermediate products
04/04/2003WO2002030896A1 2,2-diphenylbutanamide derivatives and medicines containing the same
04/04/2003CA2424979A1 2,2-diphenylbutanamide derivatives and medicines containing the same
04/03/2003WO2003027102A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
04/03/2003WO2003027076A2 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
04/03/2003WO2003027072A1 Process for the preparation of repaglinide
04/03/2003WO2002102766A3 Combretastatin a-3 prodrug
04/03/2003WO2002058632A3 Primary intermediates for oxidative coloration of hair
04/03/2003US20030065219 Cyclization of an alcohol containing urea compound
04/03/2003US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
04/03/2003US20030065153 Such as (2-(1-piperidine)ethyl)carbamate for the deacidification of paper material
04/03/2003US20030065146 Compound for use in the treatment of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease and sepsis
04/03/2003US20030065017 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists / antagonists, estrogens and progestins
04/03/2003US20030065013 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents